AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 155 filers reported holding AKEBIA THERAPEUTICS INC in Q1 2018. The put-call ratio across all filers is 0.03 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $2,312,000 | +89.7% | 282,329 | +28.1% | 0.02% | +77.8% |
| Q4 2018 | $1,219,000 | +36.8% | 220,395 | +118.3% | 0.01% | +50.0% |
| Q3 2018 | $891,000 | +8.1% | 100,948 | +22.3% | 0.01% | +20.0% |
| Q2 2018 | $824,000 | +36.4% | 82,549 | +30.2% | 0.01% | 0.0% |
| Q1 2018 | $604,000 | -22.5% | 63,398 | +21.0% | 0.01% | 0.0% |
| Q4 2017 | $779,000 | -14.6% | 52,379 | +13.0% | 0.01% | -16.7% |
| Q3 2017 | $912,000 | +81.0% | 46,372 | +32.3% | 0.01% | +50.0% |
| Q2 2017 | $504,000 | +66.3% | 35,049 | +6.3% | 0.00% | +100.0% |
| Q1 2017 | $303,000 | -20.9% | 32,970 | -10.5% | 0.00% | -33.3% |
| Q4 2016 | $383,000 | -12.8% | 36,830 | -24.0% | 0.00% | -25.0% |
| Q3 2016 | $439,000 | +10.0% | 48,460 | -9.2% | 0.00% | 0.0% |
| Q2 2016 | $399,000 | +3.9% | 53,350 | +25.2% | 0.00% | 0.0% |
| Q1 2016 | $384,000 | -26.3% | 42,622 | +5.6% | 0.00% | -20.0% |
| Q4 2015 | $521,000 | -88.1% | 40,352 | -10.6% | 0.01% | 0.0% |
| Q3 2015 | $4,360,000 | +1383.0% | 45,137 | +57.8% | 0.01% | +66.7% |
| Q2 2015 | $294,000 | +162.5% | 28,604 | +184.9% | 0.00% | +200.0% |
| Q1 2015 | $112,000 | – | 10,041 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $1,471,000 | 1.42% |
| Orchard Capital Management, LLC | 251,826 | $80,000 | 0.03% |
| GSA CAPITAL PARTNERS LLP | 486,568 | $154,000 | 0.02% |
| Icon Wealth Advisors, LLC | 400,132 | $127 | 0.02% |
| ACADIAN ASSET MANAGEMENT LLC | 7,483,053 | $2,365,000 | 0.01% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,042,816 | $646,000 | 0.01% |
| WIPFLI FINANCIAL ADVISORS LLC, | 200,000 | $63,000 | 0.00% |
| WEALTH EFFECTS LLC | 18,316 | $6,000 | 0.00% |
| James J. Burns & Company, LLC | 25,142 | $8,000 | 0.00% |
| Bayesian Capital Management, LP | 68,600 | $22,000 | 0.00% |